Insulin Patch: V-Go, CeQur Simplicity, and How Patch Pumps

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult your physician or a qualified healthcare provider regarding any medical condition or treatment.

Key Takeaways

  • An insulin patch is a small wearable device that delivers insulin without tubing — current U.S. options include the V-Go (basal plus mealtime bolus, T2D) and the CeQur Simplicity (mealtime bolus only, T2D).
  • These mechanical patches differ from tubeless patch pumps such as the Omnipod 5, which is a full pump-and-algorithm system FDA-cleared for both type 1 and type 2 diabetes.
  • Patches are most useful for people with type 2 diabetes who want simpler insulin delivery than syringes or pens, fewer injections per day, and a discrete wearable design.
  • Patches do not replace clinical decisions about insulin type, dose, or A1C goals — they are a delivery tool that still requires a prescription and careful titration.

An insulin patch is a small, tubeless wearable device that delivers insulin through a tiny cannula just under the skin. The two main mechanical patches on the U.S. market are the V-Go (basal plus mealtime bolus, single-day, for type 2 diabetes) and the CeQur Simplicity (mealtime bolus only, three-day, also for type 2 diabetes). They are simpler than full pumps and meant for people with predictable insulin needs. The tubeless Omnipod 5 is sometimes called a patch pump but is technically a full automated insulin delivery system in a patch form factor.

What “Insulin Patch” Means

Two different product categories share the “patch” label, and they are easy to confuse:

  • Mechanical insulin patches (V-Go, CeQur Simplicity) — small, single-use or short-wear devices with limited programmability, designed for simplicity in type 2 diabetes.
  • Tubeless patch pumps (Omnipod 5) — full insulin pumps in a tubeless pod form, with CGM integration, AID algorithms, and the same flexibility as tubed pumps like the Tandem t:slim X2 or Medtronic 780G.

Both stick to the skin and deliver insulin without tubing, but the underlying systems are very different in capability, cost, and intended user.

V-Go (Basal-Bolus Patch for T2D)

The V-Go is a disposable, one-day patch worn on the abdomen. The user fills it with rapid-acting insulin (Humalog, NovoLog, Fiasp, or Apidra) at the start of the day. It then delivers a preset basal rate continuously over 24 hours and lets the user manually trigger bolus doses at meals using a button on the device. Three preset basal options are available: 20, 30, or 40 units per day, with on-demand bolus delivery in 2-unit increments. After 24 hours, the patch is removed and replaced with a new one. The device is mechanical, with no electronics, no Bluetooth, and no CGM integration. It is FDA-cleared for adults with type 2 diabetes who require insulin.

Pros and Cons of the V-Go

  • Pros: simple, no tubing, fewer injections per day, discrete under clothing, no batteries or charging.
  • Cons: fixed basal options, manual bolus only in 2-unit increments, no remote control or CGM integration, limited to T2D, daily wear cost.

CeQur Simplicity (Mealtime Bolus Patch)

The CeQur Simplicity is a three-day mealtime bolus patch worn on the abdomen. It does not deliver basal insulin; users typically pair it with a long-acting basal pen (such as Lantus, Tresiba, or Toujeo). The patch is filled with rapid-acting insulin and delivers a 2-unit bolus per click. It is intended for adults with diabetes who need mealtime insulin and want to reduce the number of daily injections — replacing what would otherwise be three or more pen injections each day with a single patch worn for 72 hours.

Pros and Cons of CeQur Simplicity

  • Pros: three-day wear, discrete, no tubing, simplifies mealtime dosing, no tech learning curve.
  • Cons: bolus only (basal still needed via separate injection or pen), 2-unit dose increments, manual button delivery, primarily T2D in real-world use.

Patch Pumps: The Omnipod 5 Difference

The Insulet Omnipod 5 is sometimes lumped under “patch” because it is tubeless, but it is a full insulin pump with a sophisticated automated insulin delivery (AID) algorithm. It pairs with the Dexcom G6 or G7 CGM (and Abbott FreeStyle Libre 2 Plus) and adjusts basal insulin every five minutes via the SmartAdjust algorithm running on the pod itself. Each pod lasts up to three days and holds up to 200 units of insulin. The Omnipod 5 is FDA-cleared for both type 1 and type 2 diabetes. It costs more than mechanical patches and requires more clinical setup, but it offers far more capability.

Device Wear Time Delivery CGM Integration Indication
V-Go 24 hours Preset basal + manual bolus None Adult T2D on insulin
CeQur Simplicity 72 hours Manual bolus only (2 U/click) None Adult diabetes needing mealtime insulin
Omnipod 5 Up to 72 hours Programmable basal + bolus, AID algorithm Dexcom G6/G7, Libre 2 Plus T1D and T2D, age 2+

Who Benefits Most From an Insulin Patch

Mechanical patches like the V-Go and CeQur Simplicity make the most sense for adults with type 2 diabetes who:

  • Are already on multiple daily insulin injections and want fewer needles
  • Have relatively stable insulin requirements day to day
  • Value simplicity over advanced features
  • Want a discrete, wearable option without committing to a full pump system
  • Have insurance coverage for the device, since per-month costs add up

The Omnipod 5 better suits people with type 1 diabetes, intensively managed type 2 diabetes, or anyone who wants AID functionality. According to the ADA Standards of Care, AID systems are now recommended for many adults with type 1 diabetes, and shared decision-making is emphasized for people with type 2 diabetes who require insulin.

Practical Considerations

All insulin patches require a prescription. Insurance coverage varies — V-Go and CeQur Simplicity are usually billed under pharmacy benefits, while pumps like Omnipod 5 may be covered under either pharmacy or durable medical equipment, depending on the plan. Skin reactions to adhesives are common across all patch devices; rotating sites and using barrier products help. Site selection matters: the abdomen is most studied, with the upper arm and thigh as alternatives for some devices. Carry a backup plan — an insulin pen and short-acting injection — in case a patch fails. For broader treatment context see our treatment hub and the prediabetes overview for upstream prevention.

The Bottom Line

Insulin patches give people with type 2 diabetes a simpler, tubing-free way to take insulin, with the V-Go covering full daily dosing and the CeQur Simplicity replacing mealtime injections. They are not as flexible as a full insulin pump, and they do not replace clinical decisions about insulin type or A1C targets. If you want algorithm-driven automated dosing in a tubeless form, the Omnipod 5 is in a different category. Talk to your prescriber or diabetes care and education specialist about which option fits your insulin needs, lifestyle, and budget.

Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication or treatment plan.

Frequently Asked Questions

What is the difference between an insulin patch and an insulin pump?

An insulin patch is a simplified, often single-day device that delivers insulin through a small cannula with no tubing and minimal programmability. A full insulin pump (whether tubed or tubeless) holds days of insulin, supports flexible basal and bolus dosing, and increasingly integrates with a CGM to run an automated insulin delivery algorithm. Patches like V-Go and CeQur Simplicity are mechanical and primarily aimed at type 2 diabetes; pumps like Tandem t:slim X2 and Omnipod 5 are full electronic systems used in both T1D and T2D.

Are insulin patches FDA-approved?

Yes. The V-Go (originally developed by Valeritas, now distributed by Mannkind) is FDA-cleared for adults with type 2 diabetes who require insulin. The CeQur Simplicity is FDA-cleared for adults with diabetes (mainly T2D in real-world use) who need mealtime bolus insulin. Tubeless patch pumps such as the Omnipod 5 carry separate FDA clearances as automated insulin delivery systems for type 1 and type 2 diabetes.

Who is a good candidate for an insulin patch?

Adults with type 2 diabetes on multiple daily insulin injections who want a simpler, tubing-free option are typical candidates. The V-Go is most useful for people with relatively stable basal needs and predictable mealtime doses. The CeQur Simplicity suits people who already use a basal pen but want to reduce mealtime injections. People with type 1 diabetes or highly variable insulin needs are usually better served by a full AID patch pump like Omnipod 5.

Sources

  1. https://www.fda.gov/medical-devices/general-and-special-controls-medical-devices/general-controls-medical-devices
  2. https://professional.diabetes.org/standards-of-care
  3. https://www.cequrcorp.com/